Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have been diagnosed with cystic fibrosis (confirmed through a gene test or a sweat test) or a lung condition called non-CF bronchiectasis (confirmed by a CT scan)
- You are currently a patient under the care of Royal Papworth Hospital
- You are about to start antibiotic treatment given through a drip (IV) for an acute flare-up of your lung condition, based on a specific set of recognised symptoms (confirm with trial site)
Who may not be able to join:
- You are not able to give written consent to take part in the trial
- You have had a lung transplant or are currently on the waiting list for one
- You use long-term oxygen at home or a breathing support machine (such as a CPAP or BiPAP) to manage ongoing breathing difficulties
- You are not willing to allow anonymised data collected from home monitoring devices to be used for research
- The trial team has decided, for any reason, that home monitoring would not be suitable for you
- You are being admitted for a planned, routine course of antibiotics rather than for an unexpected acute flare-up of your condition
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andres Floto, University of Cambridge
Phone: +44 1223 638000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The change in physiological parameter measure such as heart rate (sensor dependant) between the start and end of intravenous antibiotics for acute pulmonary exacerbation.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.